Track topics on Twitter Track topics that are important to you
65 West Watkins Mill Road
United States of America
Phone: (240) 632-0740 or (877) 943-6832
Fax: (240) 632-0735
Mr. Swirsky joins the company from his position of CEO at GenVec
Pancreatic cancer gene therapy drug pulled in phase III.
Forthcoming news stories - GSK to supply free vaccines to poor Americans; GenVec shares crash after failure of late stage cancer drug trials; and Eli Lilly's plans for massive expansion in China.
Top stories on January 20th, 2010: Obama healthcare reforms "on life support" after Republican victory Turning Japanese: Novartis gets approval for three drugs GenVec in hearing loss deal with Novart...
SummaryGenVec Inc GenVec focuses on the research and development of genebased medicine. It develops therapeutics and vaccines using its proprietary adenovector gene delivery platform. The company's le...
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent-protect...
We have published hundreds of GenVec news stories on BioPortfolio along with dozens of GenVec Clinical Trials and PubMed Articles about GenVec for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GenVec Companies in our database. You can also find out about relevant GenVec Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...